Oligonucleotides
Medchemexpress LLC sEH inhibitor-7 | 340221-20-7 | 99.5% | 247.33 | 100 MG
sEH inhibitor-7 is an inhibitor of soluble epoxide hydrolase (sEH) with IC50s of 0.15 μM (mouse sEH) and 6.2 μM (human sEH). Soluble epoxide hydrolase plays an important role in the metabolism of endogenous chemical mediators involved in the regulation of blood pressure and inflammation.
- Inhibits soluble epoxide hydrolase (sEH)
- IC50s of 0.15 μM (mouse sEH)
- IC50s of 6.2 μM (human sEH)
- Plays a role in the metabolism of endogenous chemical mediators
- Involved in blood pressure regulation
- Involved in inflammation regulation
- For research use only
Medchemexpress LLC Cyclohexaneacetamide, N-(4-methoxyphenyl)- | 340221-20-7 | 99.5% | 247.33 | 1 ML
sEH inhibitor-7 (compound c-2) is an inhibitor of soluble epoxide hydrolase (sEH), demonstrating IC50s of 0.15 μM (mouse sEH) and 6.2 μM (human sEH). This compound plays a role in the metabolism of endogenous chemical mediators involved in blood pressure regulation and inflammation. It is supplied as an off-white to light yellow solid, available as a 10 mM * 1 mL solution in DMSO.
- Inhibits soluble epoxide hydrolase (sEH)
- IC50s of 0.15 μM (mouse sEH) and 6.2 μM (human sEH)
- Influences metabolism of endogenous chemical mediators
- Aids in regulation of blood pressure and inflammation
- Appears as an off-white to light yellow solid
ATCC HCM-CSHL-0727-C18; Cancer Model; Primary; Colon cancer; Human (Homo sapiens)
A patient-derived next-generation cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-CSHL-0727-C18 (ATCC No. PDM-420) was isolated from primary colon cancer tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Data for the parental tumor and the tumor-derived organoid models are available at the GDC. Additional molecular characterizations may be available at the GDC. Additional controlled data may be available via dbGaP.
ATCC HCM-BROD-0762-C49; Cancer model; Primary; Desmoid Tumor; Human (Homo sapiens)
A patient-derived next-generation cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-BROD-0762-C49 (ATCC No. PDM-625) is from primary desmoid tumor tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Data for the parental tumor and the tumor-derived organoid models are available at the GDC. Additional molecular characterizations may be available at the GDC. Additional controlled data may be available via dbGaP.
ATCC HCM-BROD-0124-C25; Cancer Model; Primary Pancreatic Adenocarcinoma Pancreas; Human (Homo sapiens)
A patient-derived next-generation cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-BROD-0124-C25 (ATCC No. PDM-137) was isolated from malignant neoplasm; primary adenocarcinoma of pancreas tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Data for the parental tumor and the tumor-derived organoid models are available at the GDC. Additional molecular characterizations may be available at the GDC. Additional controlled data may be available via dbGaP.
ATCC HCM-CSHL-0073-C25; Cancer Model Primary; Pancreatic Ductal Adenocarcinoma; Human (Homo sapiens)
A patient-derived next-generation cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-CSHL-0073-C25 (ATCC No. PDM-24) was isolated from primary adenocarcinoma of pancreas tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Data for the parental tumor and the tumor-derived organoid models are available at the GDC. Additional molecular characterizations may be available at the GDC. Additional controlled data may be available via dbGaP.
ATCC HCM-WCMC-0749-C34; Cancer model; Primary; Lung cancer; Human (Homo sapiens)
A patient-derived next-generation organoid cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-WCMC-0749-C34 (ATCC No. PDM-683) was isolated from primary lung cancer tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Please check the GDC for the availability of any data for this model.
ATCC HCM-CSHL-0059-C25; Cancer Model; Primary Adenocarcinoma Pancreatic Neck; Human (Homo sapiens)
A patient-derived next-generation organoid cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-CSHL-0059-C25 (ATCC No. PDM-101) was isolated from primary pancreatic adenocarcinoma tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Data for the parental tumor and the tumor-derived organoid models are available at the GDC. Additional molecular characterizations may be available at the GDC. Additional controlled data may be available via dbGaP.
ATCC HCM-CSHL-0147-C24; Cancer Model; Primary Adenocarcinoma Ampulla of Vater; Human (Homo sapiens)
A patient-derived next-generation cancer model generated by the Human Cancer Models Initiative (HCMI). HCM-CSHL-0147-C24 (ATCC No. PDM-102) was isolated from primary adenocarcinoma of biliary tract tissue. This tumor-derived model can be used in basic research and pharmacological screening applications. Data for the parental tumor and the tumor-derived organoid models are available at the GDC. Additional molecular characterizations may be available at the GDC. Additional controlled data may be available via dbGaP.
